As GLP-1s quiet the constant hum of hunger, are they a permanent pharmaceutical crutch, or can they create space to let us ...

Millions of dollars in a new $32.6 billion state budget proposal could allow for the return of GLP-1 coverage for some state employees.

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another medicine with ...

Pfizer has axed its oral GLP-1 asset danuglipron after one patient had potential drug-induced liver injury in a phase 1 trial ...

Researchers developing benchmarks for a blood-based test like those for measuring blood glucose and cholesterol ...